[ACRX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 0.35%
YoY- -14.13%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 818 343 740 1,487 2,659 3,109 6,435 -74.81%
PBT -10,539 -11,592 -10,588 -13,013 -13,057 -15,551 -9,682 5.83%
Tax 2 136 -703 -3,233 2 -2,704 68 -90.53%
NP -10,541 -11,592 -9,885 -13,013 -13,059 -15,551 -9,682 5.84%
Tax Rate - - - - - - - -
Total Cost 11,359 11,935 10,625 14,500 15,718 18,660 16,117 -20.85%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -1,288.63 -3,379.59 -1,335.81 -875.12 -491.12 -500.19 -150.46 320.25%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -4.07 -4.55 -3.88 -5.61 -5.76 -6.86 -4.27 -3.15%
EPS Diluted -4.07 -4.55 -3.88 -5.61 -5.76 -6.86 -4.27 -3.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.